BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 33598811)

  • 1. Different effects of p53 protein overexpression on the survival of gastric cancer patients according to Lauren histologic classification: a retrospective study.
    Kim KW; Kim N; Choi Y; Kim WS; Yoon H; Shin CM; Park YS; Lee DH; Park YS; Ahn SH; Park DJ; Kim HH; Lee HS; Kim JW; Kim JW; Lee KW; Chang W; Park JH; Lee YJ; Lee KH; Kim YH
    Gastric Cancer; 2021 Jul; 24(4):844-857. PubMed ID: 33598811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer.
    Lee KE; Lee HJ; Kim YH; Yu HJ; Yang HK; Kim WH; Lee KU; Choe KJ; Kim JP
    Jpn J Clin Oncol; 2003 Apr; 33(4):173-9. PubMed ID: 12810831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic features of gastric cancer with synchronous and metachronous colorectal cancer in Korea: are microsatellite instability and p53 overexpression useful markers for predicting colorectal cancer in gastric cancer patients?
    Kim HJ; Kim N; Choi YJ; Yoon H; Shin CM; Park YS; Lee HS; Ahn SH; Park do J; Kim HH; Son IT; Kang SB; Lee DH
    Gastric Cancer; 2016 Jul; 19(3):798-807. PubMed ID: 26445944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P53 accumulation is a prognostic factor in intestinal-type gastric carcinoma but not in the diffuse type.
    Roviello F; Marrelli D; Vindigni C; De Stefano A; Spina D; Pinto E
    Ann Surg Oncol; 1999 Dec; 6(8):739-45. PubMed ID: 10622501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
    He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
    World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic and prognostic significance of overexpression of her-2/neu and p53 oncoproteins in gastric carcinoma using tissue microarray.
    Ismail HM; Moneer M; El-Baradie M; Khorshid O; Touny A
    J Egypt Natl Canc Inst; 2007 Jun; 19(2):147-57. PubMed ID: 19034345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lauren classification combined with HER2 status is a better prognostic factor in Chinese gastric cancer patients.
    Qiu M; Zhou Y; Zhang X; Wang Z; Wang F; Shao J; Lu J; Jin Y; Wei X; Zhang D; Wang F; Li Y; Yang D; Xu R
    BMC Cancer; 2014 Nov; 14():823. PubMed ID: 25380654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Helicobacter pylori eradication after subtotal gastrectomy on the survival rate of patients with gastric cancer: follow-up for up to 15 years.
    Choi Y; Kim N; Yun CY; Choi YJ; Yoon H; Shin CM; Park YS; Ahn SH; Joong Park D; Lee HS; Kim JW; Kim JW; Lee KW; Chang W; Park JH; Lee YJ; Lee KH; Kim YH; Lee DH; Kim HH
    Gastric Cancer; 2020 Nov; 23(6):1051-1063. PubMed ID: 32361784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
    Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
    World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of mutant p53 and c-erbB-2 proteins and mutations of the p15 and p16 genes in human gastric carcinoma: with respect to histological subtypes and stages.
    Wu MS; Shun CT; Sheu JC; Wang HP; Wang JT; Lee WJ; Chen CJ; Wang TH; Lin JT
    J Gastroenterol Hepatol; 1998 Mar; 13(3):305-10. PubMed ID: 9570245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of p53 protein as a prognostic indicator of reduced survival time in diffuse-type gastric carcinoma.
    Liu XP; Tsushimi K; Tsushimi M; Oga A; Kawauchi S; Furuya T; Sasaki K
    Pathol Int; 2001 Jun; 51(6):440-4. PubMed ID: 11422805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of Human epidermal growth factor receptor-2 expression in patients with resectable gastric adenocarcinoma.
    Kim H; Seo S; Kim K; Park YH; An M; Baik H; Choi C; Oh S
    World J Surg Oncol; 2019 Jul; 17(1):122. PubMed ID: 31296222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose Transporter-1 (GLUT-1) Expression is Associated with Tumor Size and Poor Prognosis in Locally Advanced Gastric Cancer.
    Yin C; Gao B; Yang J; Wu J
    Med Sci Monit Basic Res; 2020 Mar; 26():e920778. PubMed ID: 32201432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of TM4SF1 as a tumor suppressor gene in gastric cancer.
    Peng XC; Zeng Z; Huang YN; Deng YC; Fu GH
    Cancer Med; 2018 Jun; 7(6):2592-2600. PubMed ID: 29665316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and clinical implication of S100A12 in gastric carcinoma.
    Li D; Zeng Z; Yu T; Qin J; Wu J; Song JC; Zhou ZY; Yuan JP
    Tumour Biol; 2016 May; 37(5):6551-9. PubMed ID: 26638166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased RhoA Activity Predicts Worse Overall Survival in Patients Undergoing Surgical Resection for Lauren Diffuse-Type Gastric Adenocarcinoma.
    Chang KK; Cho SJ; Yoon C; Lee JH; Park DJ; Yoon SS
    Ann Surg Oncol; 2016 Dec; 23(13):4238-4246. PubMed ID: 27364501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of serum inflammation indexes in different Lauren classification of gastric cancer.
    Yin X; Fang T; Wang Y; Wang Y; Zhang D; Li C; Xue Y
    Cancer Med; 2021 Feb; 10(3):1103-1119. PubMed ID: 33410261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Integration and analysis of associated data in surgical treatment of gastric cancer based on multicenter, high volume databases].
    Wang W; Sun Z; Deng J; Wang Z; Zhou Z; Liang H; Xu H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Feb; 19(2):179-85. PubMed ID: 26831882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of p53 predicts shorter survival in diffuse type gastric cancer.
    Lee WJ; Shun CT; Hong RL; Wu MS; Chang KJ; Chen KM
    Br J Surg; 1998 Aug; 85(8):1138-42. PubMed ID: 9718015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesothelin Expression Is a Predictive Factor for Peritoneal Recurrence in Curatively Resected Stage III Gastric Cancer.
    Shin SJ; Park S; Kim MH; Nam CM; Kim H; Choi YY; Jung MK; Choi HJ; Rha SY; Chung HC
    Oncologist; 2019 Nov; 24(11):e1108-e1114. PubMed ID: 31015316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.